Watch for Eysuvis and Other Steroid Drops for Dry Eyes

January 2021

Rx Eysuvis (loteprednol 0.25% suspension) will be the first FDA-approved ophthalmic corticosteroid for treating dry eyes.

But it’s only for up to 2 weeks of use.

We know long-term use of any ophthalmic steroid can increase the risk of glaucoma or cataracts...regardless of the steroid, strength, or formulation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote